BOSTON, May 23, 2005 – Zelos Therapeutics Inc., an early-stage therapeutics product development company, recently completed its $42.5 million Series B Preferred Stock financing.
The partner from Goodwin Procter who represented Zelos Therapeutics Inc. in this matter is Mitchell Bloom.
Related Content
- AlertApril 24, 2025
Washington Becomes First State to Adopt Filing Requirements for HSR-Reportable Transactions Outside of Healthcare
- Life Sciences PerspectivesApril 23, 2025
Charting a Conditional Approval Pathway for Rare Disease Drugs – A Top Priority for a Revamped FDA?
- InsightApril 23, 2025
Five Trends Reshaping Pharmaceutical Manufacturing Partnerships
- Big Molecule WatchApril 18, 2025
Celltrion Adalimumab Biosimilar Granted Interchangeability Designation
- Big Molecule WatchApril 15, 2025
FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs
- AlertApril 15, 2025
Life Sciences Companies Must Navigate the DOJ Data Rule
- Big Molecule WatchApril 11, 2025
FDA Approves Biocon Biologics’ Bevacizumab Biosimilar
- Big Molecule WatchApril 9, 2025
Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar
- Press ReleaseApril 28, 2025
Goodwin’s Israel Practice Highly Ranked by Chambers and Israel Desks
- Press ReleaseApril 28, 2025
SpringWorks Therapeutics To Be Acquired By Merck KGaA, Darmstadt, Germany For $3.9 Billion
- Awards and RankingsApril 24, 2025
Goodwin Tops the Q1 2025 M&A and Private Equity League Tables
- Press ReleaseApril 23, 2025
Goodwin Guides Syneron Bio on Strategic Collaboration with AstraZeneca for $75 Million and up to $3.4 Billion in Milestones
- Press ReleaseApril 23, 2025
Goodwin Represents VelaVigo on $440 Million Second Out-Licensing Deal of a First-in-Class Bi-specific Antibody
- Press ReleaseApril 17, 2025
Brink Therapeutics Raises €3.5 Million
- In the PressApril 11, 2025
Radiopharmaceuticals M&A to go Nuclear over Production Demand, Novel Drugs (Mergermarket)
- EventsApril 8, 2025
Boston Forum: Merger Control & Competition in Life Sciences